Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by L. Rubinstein
Approaches to Phase 1 Clinical Trial Design Focused on Safety, Efficiency, and Selected Patient Populations: A Report From the Clinical Trial Design Task Force of the National Cancer Institute Investigational Drug Steering Committee
Clinical Cancer Research
Cancer Research
Oncology
Randomized Phase II Designs
Clinical Cancer Research
Cancer Research
Oncology
Related publications
Phase 1 Clinical Trial of a New Antiarrhythmic Drug ME3202.
Japanese Journal of Clinical Pharmacology and Therapeutics
Pharmacology
Design of the GutHeart-targeting Gut Microbiota to Treat Heart Failure-Trial: A Phase II, Randomized Clinical Trial
ESC heart failure
Cardiovascular Medicine
Cardiology
Statistical Methods for Survival Trial Design: With Applications to Cancer Clinical Trial Using R
Journal of Biopharmaceutical Statistics
Statistics
Probability
Pharmacology
The Use of Genomics in Clinical Trial Design
Clinical Cancer Research
Cancer Research
Oncology
How to Design a Cell or Gene Therapy Clinical Trial: Advice From the FDA
Molecular Therapy
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
The Pediatric Hydroxyurea Phase III Clinical Trial (BABY HUG): Challenges of Study Design
Pediatric Blood and Cancer
Oncology
Child Health
Hematology
Perinatology
Medicine
Pediatrics
OP0105 Long-Term Safety of Tocilizumab From Large Clinical Trial and Postmarketing Populations
Hypothesis Generation and Evaluation in Clinical Trial Design
Lessons Learned From BATTLE-2 in the War on Cancer: The Use of Bayesian Method in Clinical Trial Design
Annals of Translational Medicine
Medicine
